The results of drug treatment experiments clearly demonstrated that SRSF9 expression is regulated by DNA methylation; therefore, the high expression of SRSF9 in HCC can likely be attributed to its hypomethylation status. This evidence concerns the gene SRSF9 and hepatocellular carcinoma.